You are here: Industry Insights > Press Release

News List

InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones firstwordpharma
November 09, 2018
Oversubscribed $42 Million Series B Financing Provides Significant Runway to Support Continued Advancement of Innovative Inhaled Cardiovascular Therapy
Hikma acquires Medlac, an injectable manufacturing company in Vietnam firstwordpharma
November 09, 2018
Today announces that Hikma has entered into an agreement to acquire 100 per cent of the share capital of Medlac Pharma Italy Co. Ltd. (Medlac)...
Takeda Announces Issuance of Unsecured Euro Denominated Senior Notes firstwordpharma
November 09, 2018
Osaka, Japan, November 8, 2018 --- Takeda Pharmaceutical Company Limited (TSE: 4502) (the "Company or "Takeda") announces that it is planned to launch the
Cue Biopharma Announces Strategic Collaboration with LG Chem Life Sciences for Immuno-STAT Biologics in Oncology firstwordpharma
November 09, 2018
Collaboration Expands Development and Manufacturing of Immuno-STAT™ Biologics and Broadens Coverage of Patient Populations...
Immunomedics Expands Clinical Collaboration With Astrazeneca to Include Metastatic Non-Small Cell Lung Cancer firstwordpharma
November 09, 2018
Phase 2 Platform Study to Evaluate the Combination of Imfinzi® (Durvalumab) and Sacituzumab Govitecan in Patients with Non-Small Cell Lung Cancer Who Progressed
Spero Therapeutics Announces Proposed Offering of Common Stock firstwordpharma
July 10, 2018
Spero Therapeutics, Inc. (Nasdaq:SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections
Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma firstwordpharma
July 10, 2018
Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, announces that the U.S.
Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia firstwordpharma
July 10, 2018
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, randomized, double-blind
Shionogi Regains Full Rights to Symproic (naldemedine) in the US firstwordpharma
July 10, 2018
OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE)-- Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") has announced that effective immediately
Helix BioPharma Corp. Closes Private Placement firstwordpharma
July 10, 2018
RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp.

Previous page 1 2 3 Next page